RXST News and Press, RxSight Inc.

2026-02-25 23:18:26 ET More on RxSight RxSight, Inc. (RXST) Q4 2025 Earnings Call Transcript RxSight, Inc. (RXST) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript RxSight, Inc. (RXST) Presents at 44th Annual J.P. Morgan Healthcare Conference - Sli...

2026-02-25 23:17:49 ET RxSight, Inc. (RXST) Q4 2025 Earnings Call February 25, 2026 4:30 PM EST Company Participants Oliver Moravcevic - Vice President of Investor Relations Ronald Kurtz - President, CEO & Director Mark Wilterding - Chief Financial Officer ...

2026-02-25 18:06:42 ET Image source: The Motley Fool. Feb. 25, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-25 16:39:42 ET More on RxSight RxSight, Inc. (RXST) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript RxSight, Inc. (RXST) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow RxSight guides FY revenue above previous estima...

ALISO VIEJO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter and full year ended December 31, 2025. Strategic Highlights and Recent Developments 2025 Light Adjustable Lens (LAL ® and LAL+ ® ) unit sales incr...

HCI Group Inc. (HCI) is expected to report $4.87 for Q4 2025 XPEL Inc. (XPEL) is expected to report $0.43 for Q4 2025 Oversea-Chinese Banking Corporation Limited ADR (OVCHY) is expected to report $0.56 for Q4 2025 UMH Properties Inc. (UMH) is expected to report $0.24 for Q4 2025 I...

ALISO VIEJO, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, will report financial results for the fourth quarter and full year 2025 after the market close o...

2026-01-13 21:45:57 ET RxSight, Inc. (RXST) 44th Annual J.P. Morgan Healthcare Conference January 13, 2026 6:45 PM EST... Read the full article on Seeking Alpha For further details see: RxSight, Inc. (RXST) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-12 02:22:02 ET More on RxSight RxSight, Inc. (RXST) Q3 2025 Earnings Call Transcript RxSight down on CFO transition RxSight narrows 2025 revenue guidance to $125M–$130M while elevating gross margin outlook amid evolving commercial strategy Seek...

ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced certain preliminary unaudited financial and operational resu...